Search

everythinglearnresearchcommunity

for

Search:↓

Erlotinib can cause hair loss as a side effect.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

A 6-year-old girl with head lice developed scarring hair loss but improved with treatment.

Hair transplantation is safe and effective for children with scar-related hair loss.

The link between pemphigus and the patient's scarring hair loss is still unclear.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Hyaluronic acid injections can cause hair loss due to blocked blood vessels.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

CCCA may be caused by both hair traction and an immune response.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Dermoscopy helped correctly diagnose a skin condition that was previously misidentified as a different hair loss disease.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Long hair can cause hair loss due to constant pulling.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Hair transplants can work for permanent hair loss if the condition is stable and done carefully.

Primary cicatricial alopecia significantly reduces life quality, mainly due to pain and anxiety.

Dermoscopy is a useful, low-cost method for diagnosing various types of hair loss disorders known as Cicatricial Alopecia.

The document concludes that there are various treatments for diseases linked to scarring hair loss, especially for primary scarring alopecia.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.